
Watch this webinar and learn how Dr. Olivier Harismendy from UC San Diego developed and implemented an assay that targets ~100kb of mutational hotspots in cancer. He dicussed its technical validity for the identification of low-prevalence mutations in heterogeneous cancer samples. RainDance Technologies is pioneering digital biology and powering ground-breaking human health and life science research with its novel droplet-based technologies. The power, precision and simplicity of picodroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation.
